Abstract:BACKGROUND Cardiovascular dysfunction frequently occurs after major vascular surgery or liver transplantation. OBJECTIVE To evaluate the effects on myocardial activity of vasoactive agents released from ischemic-reperfused liver. ANIMALS AND METHODS Isolated rat livers were perfused with Krebs-Henseleit solution (KH), propranolol 10(-5) M, losartan 2x10(-5) M and indomethacin 10(-5) M, then made globally ischemic for 120 min (37 degrees C) and reperfused. Isolated hearts from other rats were stabilized with KH and reperfused for 15 min with the perfusate exiting the livers. Livers were disconnected, and the hearts continued to be recirculated with the accumulated liver and heart effluent for an additional 50 min. Enzyme leakage, different vasoactive substances, left ventricular developed pressure (LVP) and coronary flow were measured during the experimental protocol. RESULTS Hepatic release of adrenaline, noradrenaline, angiotensin II, prostaglandin E(2) and thromboxane B(2) was significantly increased in the liver effluent following ischemia. When this effluent was directed to the heart, LVP was significantly raised in the first 10 min of reperfusion (137+/-5%) followed by marked decreased (46+/-6%) during the following 65 min of myocardial reperfusion. In the ischemic-reperfused drug-treated groups, the initial positive effect on LVP was milder than in controls (propranolol 112+/-12%, losartan 111+/-11%, indomethacin 113+/-9%) and the final LVP was lower (propranolol 29+/-6%, losartan 27+/-7% [P<0.05 versus ischemic control], indomethacin 46 +/-12%). CONCLUSION During the initial phase of reperfusion, vasoactive substances released in the hepatic effluent potentiated LVP of the hearts exposed to this effluent. When the three inhibitory drugs were added to KH, this initial augmentation was not sustained. Propranolol and losartan, but not indomethacin, further depressed LVP. Vasoactive substances released from ischemic reperfused livers directly influenced heart function.

Enzymatic Removal of Paracetamol from Aqueous Phase: Horseradish Peroxidase Immobilized on Nanofibrous Membranes.

Horseradish Peroxidase Immobilized in Macroporous Hydrogel for Acrylamide Polymerization

HRP Immobilization on Activated Carbon/Polyvinyl Formal Composite Materials for Degradation of Phenolic Wastewater

Immobilization of Horseradish Peroxidase on Ca Alginate-Starch Hybrid Support: Biocatalytic Properties and Application in Biodegradation of Phenol Red Dye

Immobilization of Horseradish Peroxidase for Phenol Degradation

Removal of Pentachlorophenol Catalyzed by Immobilized Horseradish Peroxidase

Paracetamol transport by ZnO nanoparticle-doped polymer-containing membrane

Removal of Pentachlorophenol (PCP) by Immobilized Horseradish Peroxidase (HRP)

Removal of Pentachlorophenol by Immobilized Horseradish Peroxidase

Oriented Membrane Processes for the Treatment of Wastewater from the Pharmaceutical Industry Loaded with Paracetamol Compound

First-degree atrioventricular block and pseudopacemaker syndrome.

Influence of oxidized starch on the properties of thermoplastic starch.

Preparation and Application of Horseradish Peroxidase Immobilized in Fe3O4-Asorption-Gelatin-Entrapping Method

Immobilized enzymatic membrane surfaces for biocatalytic organics removal and fouling resistance

THERMOSENSITIVE NANOCAPSULES FOR EFFECTIVE IMMOBILIZATION AND RECYCLING OF HORSERADISH PEROXIDASE

Effects of vasoactive substances released from ischemic reperfused liver on the isolated rat heart.

Paracetamol and amoxicillin adsorptive removal from aqueous solution using phosphoric acid activated-carbon

Preparation of Coaxial-Electrospun Poly[bis(p-methylphenoxy)]phosphazene Nanofiber Membrane for Enzyme Immobilization

An Immobilized Lipase with High Enantioselectivity in the Resolution of Racemic Ibuprofen

A Complete Year of User Retrieval Sessions in a Social Sciences Academic Search Engine

Removal of Acetaminophen from Aqueous Solutions in an Adsorption Process